BioSpace News Archive

ViaClean Technologies, a biotech company that develops, manufactures and markets environmentally responsible solutions that protect life’s surfaces, announced the appointment of Greg Tipsord as President and Chief Executive Officer.

BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for unmet medical need, announces that bemcentinib has been selected as the first potential treatment to be fast-tracked in a new UK national multi-centre randomised Phase II clinical trial initiative

Immunomedics, Inc., a leading biopharmaceutical company in the area of antibody-drug conjugates, announced the pricing of an underwritten public offering of 14,736,860 shares of its common stock at a public offering price of $28.50 per share, representing gross proceeds of approximately $420 million.

MedX Health Corp. is pleased to announce that further to the Conditional Approval from the TSX Venture Exchange for a non-brokered Private Placement to accredited investors of up to 25,000,000 units at $0.12 per unit, to raise up to $3,000,000 that was announced on March 6, 2020, the closing of two tranches of that placement have taken place, the first on April 22, and the second on April 27, 2020, for a total of 9,908,006 units, raising a total of $1,188,960.